K284-4673 Screening compound: 4-[(4-oxo-2-{[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]sulfanyl}-3,4-dihydroquinazolin-3-yl)methyl]-N-(2-phenylethyl)cyclohexane-1-carboxamide

Chemical Structure Depiction of ChemDiv screening compound K284-4673
4-[(4-oxo-2-{[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]sulfanyl}-3,4-dihydroquinazolin-3-yl)methyl]-N-(2-phenylethyl)cyclohexane-1-carboxamide

Available from 1 mg

Formats:

Glass Vials (4ml Glass Vials VWR #97047-678)
96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Check Price and Availability

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K284-4673

Molecular Formula

C₃₆H₄₁N₅O₃S (C36 H41 N5 O3 S)

Compound Name

4-[(4-oxo-2-{[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]sulfanyl}-3,4-dihydroquinazolin-3-yl)methyl]-N-(2-phenylethyl)cyclohexane-1-carboxamide

IUPAC name

4-[(4-oxo-2-{[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]sulfanyl}-34-dihydroquinazolin-3-yl)methyl]-N-(2-phenylethyl)cyclohexane-1-carboxamide

SMILES

O=C(CSC(N1CC(CC2)CCC2C(NCCc2ccccc2)=O)=Nc(cccc2)c2C1=O)N(CC1)CCN1c1ccccc1

InChI

InChI=1S/C36H41N5O3S/c42-33(40-23-21-39(22-24-40)30-11-5-2-6-12-30)26-45-36-38-32-14-8-7-13-31(32)35(44)41(36)25-28-15-17-29(18-16-28)34(43)37-20-19-27-9-3-1-4-10-27/h1-14,28-29H,15-26H2,(H,37,43)

InChI Key

CMMKTCPIKKYRBT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15088424

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

623.82

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

Partition Coefficient, logP

4.992

Distribution Coefficient, logD

4.992

Water Solubility, LogSw

-4.80

Polar Surface Area

69.871

Acid Dissociation Constant (pK_a)

13.94

Base Dissociation Constant (pK_b)

5.55

Number of Chiral Centers

0.00

Percent sp³ carbon bonding

38.90

K284-4673 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

GPCR Targeted Library (31838 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:

Antiviral
Infections
Immune system
Antiviral
Infections
Immune system
Musculoskeletal
Respiratory tract
Nervous system
Congenital
Skin
Metabolic
Endocrine
Antiviral
Infections
Immune system
Musculoskeletal
Digestive system
Hemic and lymphatic
Cardiovascular
Skin
wounds

Mechanism of action:

PPI modulators
Receptor's ligands
PPI modulators

Structure:

Cyclic compounds

Targets:

GPCR

References: we are preparing a list of scientific research reports with K284-4673 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K284-4673?
Check Price and Availability of K284-4673, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.

What is the minimum amount of K284-4673 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.

Delivery options for K284-4673
ChemDiv sends parcels with Express services (UPS, WC).

1–2 days for small orders
2–4 weeks for large selections

Delivery formats for K284-4673

0.5–50 mg of dry powder sample in single glass vials, custom vials
DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K284-4673 available by request